BIIB vs CCS · P/E 21, rev $9.89B vs P/E 6.3, rev $1.72B
Biogen Inc (BIIB) versus Century Communities Inc (CCS) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ.
Century Communities Inc (CCS) is a real estate - development company listed on US.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported CCS revenue for 2026-06-30 was $1.72B. Net income was $60.6M. CCS currently screens at market cap $1.86B and trailing P/E 6.3.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. CCS currently screens at market cap $1.86B and trailing P/E 6.3.
Not investment advice. Open the BIIB and CCS stock pages for the full models.
Not investment advice.